ClinicalTrials.Veeva

Menu

Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar) (FAST)

U

University Hospital Heidelberg

Status

Enrolling

Conditions

Ischemic Stroke
Cardiovascular Diseases
Vascular Diseases

Treatments

Other: not applicable (observational study)

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

FAST is an investigator-initiated multicenter study embedded in a German multistate acute stroke network. The main objectives of the FAST study are to improve outcomes and quality of care for stroke patients, to quantify the number of patients in need of thrombectomy within an integrated stroke network, to study the best way of delivering and performing thrombectomy and to investigate the best model of pre-hospital selection and referral for stroke patients.

Full description

Since 2015, mechanical thrombectomy in patients with large vessel occlusion has become an evidence based highly efficient treatment. In contrast to thrombolysis, thrombectomy can only be delivered by qualified interventionalists at comprehensive stroke centers. Thus, the implementation of thrombectomy into clinical practice remains a challenge. The investigators aim to establish a population based approach within a patient registry in a federal state overarching regional stroke network covering over 4 million inhabitants and integrating approximately 30 hospitals with different levels of expertise. The registry will include data from all acute ischemic stroke patients - approx. 12.000 patients p.a - within the network. The investigators plan to establish a central multi-interface platform integrating clinical data from the prehospital, intrahospital and rehabilitation phase including mandatory quality assurance, neurological and neuroradiological treatment and outcome data. The registry will allow addressing important questions, such as how many patients are candidates for thrombectomy, how many resources are needed to meet that demand and how treatment procedures and times can be improved. The overarching aim is to deliver high quality stroke care to every patient in the region.

Enrollment

12,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Patients with ischemic stroke who are admitted to one of the hospitals of the Stroke Consortium Rhein-Neckar (FAST)
  • informed consent

Exclusion criteria

  • no informed consent

Trial design

12,000 participants in 3 patient groups

Primary CSC (Comprehensive Stroke center) admission
Description:
Patients with primary admission to endovascular-ready hospital (comprehensive stroke center)
Treatment:
Other: not applicable (observational study)
Primary non-CSC (non-Comprehensive Stroke Center) SU (Stroke Unit) admission
Description:
Patients with primary admission to non-endovascular-ready hospital with (regional/local) stroke unit
Treatment:
Other: not applicable (observational study)
Non-acute stroke hospital admission
Description:
Patients with primary admission to non-acute stroke-ready hospital
Treatment:
Other: not applicable (observational study)

Trial contacts and locations

1

Loading...

Central trial contact

Loraine Busetto, Dr.; Maja Zenz, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems